The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Kidney Pathology for the Rheumatologist: Tips from an Expert

Kidney Pathology for the Rheumatologist: Tips from an Expert

June 18, 2022 • By Samantha C. Shapiro, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Why do these different deposits matter? “Clinical findings correlate with patterns of injury, and even the best clinicians can’t predict lupus nephritis class based on clinical picture alone,” Dr. Fogo explained. “That’s why we do biopsies. Mesangial deposits don’t cause a lot of problems—just some minor proteinuria and hematuria. But with endocapillary injury, you see hematuria, loss of glomerular filtration rate and proteinuria. Remember, subendothelial deposits are bad. With epithelial injury, you see nephrotic range proteinuria due to irritation of the podocytes.”2

You Might Also Like
  • Monthly Belimumab Infusions Preserve Kidney Function in Some Lupus Patients
  • Challenging Cases in Osteoporosis: Tips from an Expert
  • Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report
Explore This Issue
July 2022
Also By This Author
  • Eye-Opening Experiences: Tips from a Rheumatology-Ophthalmology Clinic

Other Lupus Kidney Diseases

Dr. Fogo then turned her attention to other types of kidney disease in SLE. “There’s more than just lupus nephritis, and a biopsy is essential for a specific diagnosis, especially given the therapeutic implications,” she said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Example: Podocytopathies distinct from lupus nephritis class V may cause proteinuria. Both minimal-change, disease-like lesions and collapsing lesions, such as those seen in HIV, can occur in SLE. Vascular lesions may range from bland deposits that don’t affect prognosis to more severe lesions with poor prognosis (e.g., lupus vasculopathy, lupus vasculitis and thrombotic microangiopathies).

‘Lupus nephritis class numbers aren’t sequential. Patients can start at any one number &, spontaneously or in response to an intervention, change to another—for better or for worse. [Patients with] lupus nephritis can also relapse [to] any form.’ —Dr. Fogo

Crescents

To talk about crescents, Dr. Fogo shared Edvard Munch’s painting The Scream. We know crescents are bad, but what else does a renal pathologist want us to know about them?

“First of all, crescents aren’t a disease,” Dr. Fogo said. “They’re a pattern of severe injury that happens when you break the capillary wall. Clinically, the syndrome is rapidly progressive glomerulonephritis, which is also not a disease. The indication for biopsy should never be to rule out rapidly progressive glomerulonephritis because that doesn’t make sense. You wouldn’t order a biopsy to rule out nephrotic syndrome, would you?”

Clinicopathological correlation, serologic studies, immunofluorescence and electron microscopy are crucial to understanding the specific cause of crescents and/or rapidly progressive glomerulonephritis. When it comes to rheumatology, four major causes are on the differential: immune-complex glomerulonephritis, such as lupus nephritis; anti-glomerular basement membrane (anti-GBM) disease; pauci-immune glomerulonephritis, as seen in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV); and IgA vasculitis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Fogo shared pearls of wisdom specific to anti-GBM disease, a pulmonary-renal syndrome caused by autoantibodies to type IV collagen. “About 25% of anti-GBM disease patients make perinuclear-ANCAs, too,” she said. “It’s important to check ANCAs in these patients, especially if they have vasculitic skin lesions. And about 15% of anti-GBM patients are seronegative, despite linear deposition of immunoglobulin along the GBM and crescentic glomerulonephritis consistent with this diagnosis. This may be due to anti-GBM antibodies with very high affinity that are all stuck in the kidneys or unusual anti-GBM antibodies not detected by standard assays. Thus, a biopsy is always needed to confirm the diagnosis.”3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Education & Training, Meeting Reports Tagged With: ACR Education Exchange, kidney, kidney disease, Lupus nephritis, pathologyIssue: July 2022

You Might Also Like:
  • Monthly Belimumab Infusions Preserve Kidney Function in Some Lupus Patients
  • Challenging Cases in Osteoporosis: Tips from an Expert
  • Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report
  • Diagnosing & Managing Pulmonary & Kidney Manifestations in Lupus

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)